Marksans Pharma Limited (BOM:524404)
India · Delayed Price · Currency is INR 305.20
+5.30 (1.77%)
At close: Oct 28, 2026
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 138.31 billion as of October 28, 2026. Its market cap has increased by 71.34% in one year.
Market Cap
138.31B
Enterprise Value
132.13B
Revenue
31.72B
Global Rank
n/a
Country Rank
n/a
PE Ratio
26.78
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 138.31B, an increase of 3,687.57%. That is a compound annual growth rate of 20.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 138.31B | 69.28% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 249.89B |
| Pfizer | 170.95B |
| Marksans Pharma | 138.03B |
| CORONA Remedies | 131.62B |
| Sanofi Consumer Healthcare India | 77.57B |
| Senores Pharmaceuticals | 60.86B |
| SMS Pharmaceuticals | 41.86B |
| Sai Parenteral's | 21.13B |